Allotment of equity shares under the MedPlus Employee Stock Option Plan, 2021

Board approves final dividend

Pursuant to Regulation 30 of SEBI(LODR), 2015, this is to inform you that M/s. C.P. Shah & Associates of the Company with immediate effect.

Board of Directors recommended dividend subject to approval by shareholders of the company in AGM

Please find enclosed herewith the Audited (Standalone & Consolidated) Financial Results for the quarter and year ended March 31, 2025.

Outcome of Board Meeting for declaration of Audited Financial Results for the quarter and Financial Year ended 31st March 2025

Financial Results for quarter and year ended on 31st March, 2025

Earning Call Recording for Q4&FY25

NAPS Global India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve 1. The Audited Financial Results for the half year and year ended March 31, 2025. 2. The Appointment of M/s. M. Rupareliya & Associates, Practicing Company Secretaries, as the Secretarial Auditor of the Company for F.Y. 2025-26 and 2026-27. 3. Any other matter with the permission of the Chair

Pursuant to regulation 30 of SEBI (LODR), 2015, this is inform you that M/s. G R Shah & Associates has been appointed as Secretarial Auditor with immediate effect.